Background And Purpose: Depression is closely linked with microglial activation and neuro-inflammation. Peroxisome proliferator-activated receptor-γ (PPAR-γ) plays an important role in M2 activation of microglia. Forkhead box (FOX) O3a has been implicated in the regulation of mood-relevant behaviour. However, little is known about the inflammatory mechanisms of in the microglia of the brain. Here, we have investigated the role of microglial FOXO3a/PPAR-γ in the development of depression.
Experimental Approach: The effect of FOXO3a on microglia inflammation was analysed in vitro and in lipopolysaccharide (LPS)-induced depression-like behaviours in vivo. ChIP-seq and Dual-luciferase reporter assays were used to confirm the interaction between FOXO3a and PPAR-γ. Behavioural changes were measured, while inflammatory cytokines, microglial phenotype and morphological properties were determined by ELISA, qRT-PCR, western blotting and immunostaining.
Key Results: Overexpression of FOXO3a significantly attenuated expression of PPAR-γ and enhanced the microglial polarization towards the M1 phenotype, while knockdown of FOXO3a had the opposite effect. FOXO3a binds to the promoters of PPAR-γ and decreases its transcription activity. Importantly, deacetylation and activation of FOXO3a regulate LPS-induced neuro-inflammation by inhibiting the expression of PPAR-γ in microglia cells, supporting the antidepressant potential of histone deacetylase inhibitors. Microglial FOXO3a deficiency in mice alleviated LPS-induced neuro-inflammation and depression-like behaviours but failed to reduce anxiety behaviour, whereas pharmacological inhibition of PPAR-γ by GW9662 restored LPS-induced microglial activation and depressive-like behaviours in microglial FOXO3a-deficient mice.
Conclusion And Implications: FOXO3a/PPAR-γ axis plays an important role in microglial activation and depression, identifying a new therapeutic avenue for the treatment of major depression.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/bph.16474 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Discovery of novel protective agents for infection-related delirium through bispectral electroencephalography.
Transl Psychiatry
October 2024
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.
Article Synopsis
- Delirium is a fluctuating mental condition that increases risks of long hospital stays, health complications, and death, but diagnosing it objectively is challenging.
- Recent studies show that bispectral electroencephalography (BSEEG) can effectively diagnose delirium and predict patient outcomes, potentially serving as a vital sign.
- In experiments with a mouse model, two compounds, P7C3-A20 and minocycline, successfully prevented delirium symptoms caused by infections, while haloperidol did not, suggesting new therapeutic avenues for protecting patients from delirium.
Targeting Toll-like Receptor 4/Nuclear Factor-κB and Nrf2/Heme Oxygenase-1 Crosstalk via Trimetazidine Alleviates Lipopolysaccharide-Induced Depressive-like Behaviors in Mice.
J Neuroimmune Pharmacol
September 2024
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El Aini St, Cairo, Egypt.
Article Synopsis
- Depression is a significant global health issue that often leads to economic challenges, and traditional antidepressants frequently cause side effects that hinder patient adherence to treatment.
- This study evaluated the effects of trimetazidine (TMZ), an anti-ischemic drug, on depression in a mouse model, focusing on its influence on key signaling pathways linked to inflammation and oxidative stress.
- The findings indicated that TMZ reduced signs of despair in treated mice, improved neuronal health, and showed potential as a new treatment option for depression by modulating specific biological pathways, necessitating further studies in humans.
Calorie restriction increases the sensitivity of progeroid Ercc1 mice to acute (neuro)inflammation.
Geroscience
September 2024
Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Hospitalized elderly patients frequently suffer from delirium, especially in the context of sepsis-associated encephalopathy. Current treatments of delirium are merely symptomatic. Calorie restriction (CR) is both a promising strategy to protect against sepsis and has beneficial effects on aging-induced neurodegeneration.
View Article and Find Full Text PDFβ-Hydroxybutyrate and melatonin suppress maladaptive UPR, excessive autophagy and pyroptosis in Aβ 1-42 and LPS-Induced SH-SY5Y cells.
Mol Biol Rep
July 2024
Endocrinology and Metabolism Research Center, Shiraz University of Medical Science, Shiraz, Iran.
Background: Alzheimer's disease is a neurological disease characterized by the build-up of amyloid beta peptide (Aβ) and lipopolysaccharide (LPS), which causes synapse dysfunction, cell death, and neuro-inflammation. A maladaptive unfolded protein response (UPR), excessive autophagy, and pyroptosis aggravate the disease. Melatonin (MEL) and hydroxybutyrate (BHB) have both shown promise in terms of decreasing Aβ pathology.
View Article and Find Full Text PDFThe Neuroprotective Effects of Extract in SHSY-5Y Neuronal Cells by Upregulating BDNF Gene Expression under LPS Induced Inflammation.
Nutrients
June 2024
Department of Horticultural Sciences, Texas A&M University, College Station, TX 77843, USA.
The brain-derived neurotrophic factor (BDNF) plays a crucial role during neuronal development as well as during differentiation and synaptogenesis. They are important proteins present in the brain that support neuronal health and protect the neurons from detrimental signals. The results from the present study suggest BDNF expression can be increase up to ~8-fold by treating the neuroblastoma cells SHSY-5Y with an herbal extract of (50 μg/mL) and ~5.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!